On CNBC's Mad Money, Jim Cramer said that Gilead Sciences, Inc. GILD has to do an acquisition. Without it, the stock is not going to move higher, because the company has a lot of cash and not a lot of growth.
Market News and Data brought to you by Benzinga APIsCramer thinks Citigroup Inc C was well prepared for the stress test, and he believes it is a buy at its current price.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in